VERTEX PHARMACEUTICALS INC / MA — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Parini Michael | EVP, Chief Adm, Leg & BD Off | Sale | 25 | $224.34 | $5,609 | 26,838 | Nov 16, 2020 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | Sale | 5 | $224.11 | $1,121 | 35,179 | Nov 16, 2020 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 18 | $223.57 | $4,024 | 28,912 | Nov 16, 2020 |
| SACHS BRUCE I | — | Purchase | 6,825 | $216.47 | $1,477,408 | 18,035 | Nov 10, 2020 |
| Parini Michael | EVP, Chief Adm, Leg & BD Off | Option Exercise | 2,330 | $86.52 | $201,592 | 29,168 | Nov 4, 2020 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | Sale | 245 | $212.38 | $52,033 | 35,513 | Nov 3, 2020 |
| Bhatia Sangeeta N. | — | Sale | 892 | $264.60 | $236,023 | 12,647 | Oct 5, 2020 |
| MCGLYNN MARGARET G | — | Gift | 3,707 | — | — | 877 | Aug 25, 2020 |
| Silva Paul M | SVP & Controller | Option Exercise | 466 | $187.53 | $87,389 | 15,398 | Aug 6, 2020 |
| Parini Michael | EVP, Chief Adm, Leg & BD Off | Sale | 422 | $271.45 | $114,552 | 27,149 | Aug 6, 2020 |
| Kewalramani Reshma | CEO & President | Option Exercise | 1,564 | $187.53 | $293,297 | 28,190 | Aug 6, 2020 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 490 | $270.12 | $132,359 | 29,635 | Aug 6, 2020 |
| Sachdev Amit | EVP, Chief Patient Officer | Sale | 751 | $279.18 | $209,664 | 35,103 | Aug 3, 2020 |
| Silva Paul M | SVP & Controller | Sale | 310 | $277.73 | $86,096 | 15,380 | Aug 3, 2020 |
| Parini Michael | EVP, Chief Adm, Leg & BD Off | Sale | 730 | $279.41 | $203,969 | 26,838 | Aug 3, 2020 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | Option Exercise | 1,553 | $86.52 | $134,366 | 36,732 | Aug 3, 2020 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 100 | $279.98 | $27,998 | 28,902 | Aug 3, 2020 |
| Silva Paul M | SVP & Controller | Sale | 250 | $294.99 | $73,748 | 15,032 | Jul 13, 2020 |
| Parini Michael | EVP, Chief Adm, Leg & BD Off | Sale | 100 | $296.48 | $29,648 | 26,838 | Jul 13, 2020 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sale | 400 | $292.86 | $117,144 | 16,386 | Jul 10, 2020 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | Option Exercise | 1,222 | $155.57 | $190,107 | 37,965 | Jul 7, 2020 |
| LEIDEN JEFFREY M | Executive Chairman | Sale | 1,318 | $287.91 | $379,465 | 5,495 | Jun 30, 2020 |
| MCKENZIE DIANA | — | Award / Grant | 1,435 | — | — | 1,435 | Jun 3, 2020 |
| Bhatia Sangeeta N. | — | Award / Grant | 1,398 | — | — | 6,647 | Jun 2, 2020 |
| MCGLYNN MARGARET G | — | Award / Grant | 699 | — | — | 4,584 | Jun 1, 2020 |
| Garber Alan M | — | Award / Grant | 699 | — | — | 5,890 | Jun 1, 2020 |
| CARNEY LLOYD | — | Award / Grant | 1,398 | — | — | 3,559 | Jun 1, 2020 |
| Bozic Carmen | EVP and CMO | Tax Withholding | 311 | $282.74 | $87,932 | 13,991 | May 29, 2020 |
| Kewalramani Reshma | CEO & President | Sale | 2 | $274.37 | $549 | 26,723 | May 15, 2020 |
| Tatsis Ourania | EVP, Chief Regulatory Officer | Sale | 17 | $279.93 | $4,759 | 12,831 | May 15, 2020 |
| Silva Paul M | SVP & Controller | Sale | 10 | $275.71 | $2,757 | 15,073 | May 15, 2020 |
| Sachdev Amit | EVP, Chief Patient Officer | Sale | 3 | $276.21 | $829 | 35,157 | May 15, 2020 |
| Parini Michael | EVP, Chief Adm, Leg & BD Off | Sale | 4 | $283.03 | $1,132 | 26,881 | May 15, 2020 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | Sale | 24 | $287.62 | $6,903 | 35,188 | May 15, 2020 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 15 | $287.19 | $4,308 | 28,921 | May 15, 2020 |
| LEIDEN JEFFREY M | Executive Chairman | Sale | 100 | $288.42 | $28,842 | 34,983 | May 12, 2020 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 1,304 | $287.33 | $374,678 | 28,902 | May 12, 2020 |
| Sachdev Amit | EVP, Chief Patient Officer | Sale | 1,817 | $280.77 | $510,159 | 42,295 | May 11, 2020 |
| Parini Michael | EVP, Chief Adm, Leg & BD Off | Sale | 1,304 | $286.00 | $372,944 | 26,838 | May 11, 2020 |
| SACHS BRUCE I | — | Option Exercise | 22,500 | $59.55 | $1,339,875 | 33,710 | May 7, 2020 |
| LEIDEN JEFFREY M | Executive Chairman | Sale | 24,617 | $268.63 | $6,612,865 | 104,681 | May 7, 2020 |
| Tatsis Ourania | EVP, Chief Regulatory Officer | Sale | 330 | $274.13 | $90,463 | 12,768 | May 6, 2020 |
| Silva Paul M | SVP & Controller | Sale | 79 | $269.41 | $21,283 | 15,929 | May 6, 2020 |
| Sachdev Amit | EVP, Chief Patient Officer | Option Exercise | 669 | $131.89 | $88,234 | 35,772 | May 6, 2020 |
| Parini Michael | EVP, Chief Adm, Leg & BD Off | Option Exercise | 1,222 | $155.57 | $190,107 | 28,060 | May 6, 2020 |
| Kewalramani Reshma | CEO & President | Sale | 416 | $270.35 | $112,466 | 28,284 | May 6, 2020 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 280 | $274.35 | $76,818 | 28,902 | May 6, 2020 |
| LEIDEN JEFFREY M | Executive Chairman | Sale | 11,832 | $272.12 | $3,219,724 | 64,880 | May 5, 2020 |
| Sachdev Amit | EVP, Chief Patient Officer | Sale | 403 | $272.58 | $109,850 | 35,303 | May 4, 2020 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | Sale | 240 | $262.54 | $63,010 | 35,292 | May 4, 2020 |